The risk of Alzheimer's disease increases as a result of mutations in the TREM2 gene, which is known to improve brain health. The gene activates the brain immune cells to eliminate toxic deposits- causative agent in the early stages of the disease. These findings provide scope for developing new drugs.
A hallmark of Alzheimer's disease is the formation of toxic deposits in the brain, so-called plaques. Specialized immune cells termed microglia protect the brain by clearing it from these toxic debris. TREM2 is a key factor in activating microglia and thus serves as an important target for novel therapeutic approaches. To further explore these therapeutic options, the Munich scientists undertook a detailed analysis of disease development in mice with and without a functional TREM2 gene.
Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.
Advertisement
‘The gene TREM2 activates the specialized immune cells called microglia in the brain to eliminate the toxic plaque that starts forming from the early stages of the Alzheimer’s disease.’
Tweet it Now
In mice with healthy TREM2, microglia cluster around small emerging plaques early in the disease process and prevent them from enlarging or spreading. "We were able to show that microglia are specifically attracted to amyloid plaques. They surround individual plaques and engulf them piece by piece," explains lead investigator Christian Haass, speaker of the DZNE's Munich site, and a professor at the Ludwig-Maximilians-University Munich. In contrast, in mice lacking TREM2, microglia were unable to carry out this important task. Therapeutic activation of TREM2 in an early stage of the disease could thus help counteract the formation of toxic amyloid-beta protein aggregates.
However, the study results also call for caution when implementing such a therapy. While TREM2 prevents plaque formation early in disease progression, it may have the opposite effect later on. In more advanced stages of the disease, the plaques grew faster in mice with functional TREM2 than in mice lacking the corresponding gene. The researchers discovered that this could be explained by the fact that TREM2 induces microglia to produce a substance called ApoE, which enhances aggregate formation. "Our study shows that we have to be extremely careful and investigate a new therapeutic approach thoroughly in animal models before testing it on humans," says Haass. "According to our findings, it could have dramatic consequences if we over-activate microglia."
![Genetic Testing of Diseases]( "Genetic Testing of Diseases")
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laboratory techniques
"In the future, it will be important to treat Alzheimer's disease in a stage-specific manner," Haass explains. According to the present study, for example, activating microglia via TREM2 would be a strategy that should be applied early in disease progression. Haass and his colleagues are currently working on the development of antibodies that stabilize TREM2 and thereby activate microglia. The scientists are now using several animal models and different experimental approaches to test possible therapeutic strategies and combination therapies with other drugs.
"All important genetic alterations that increase the risk of Alzheimer's disease lead to changes in plaque formation," Haass explains. This suggests that these protein aggregates are the cause of the disease. The current study provides hope that it is possible to counteract plaque formation by activating TREM2, and at the same time highlights potential risks that scientists need to take into account when pursuing such an approach.
Source: Eurekalert
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laboratory techniques
Advertisement
"In the future, it will be important to treat Alzheimer's disease in a stage-specific manner," Haass explains. According to the present study, for example, activating microglia via TREM2 would be a strategy that should be applied early in disease progression. Haass and his colleagues are currently working on the development of antibodies that stabilize TREM2 and thereby activate microglia. The scientists are now using several animal models and different experimental approaches to test possible therapeutic strategies and combination therapies with other drugs.
"All important genetic alterations that increase the risk of Alzheimer's disease lead to changes in plaque formation," Haass explains. This suggests that these protein aggregates are the cause of the disease. The current study provides hope that it is possible to counteract plaque formation by activating TREM2, and at the same time highlights potential risks that scientists need to take into account when pursuing such an approach.
Source: Eurekalert
13 Daily Habits that Damage the Brain
The brain is probably the most important organ in our body and it deserves special care and attention to keep it active and functioning well. Here are thirteen daily habits, you must know that can cause damage to your brain.
Advertisement
 7 Ways How Writing by Hand Improves Brain PowerDo you want to sharpen the way your brain works? Try writing by hand to sharpen your mind and increase your focus. | Advertisement
|
Advertisement
Recommended Readings
Latest Senior Health News
Elderly transgenders face a higher risk of suicide due to socio-economic factors with 25% of them giving serious thought to taking their own lives.
A decrease of 1% in deep sleep annually for individuals aged 60 and above results in a 27% higher dementia risk.
In seniors, engaging in a single session of either 18 holes of golf, 6 km of Nordic walking, or 6 km of regular walking was observed to boost cognitive functions.
Higher triglycerides linked to slower cognitive decline in various aspects, incl. global function, memory, & more over time.
In aged mice, decitabine, the anti-cancer drug demonstrated enhancements in vascular repair, inflammation resolution, and overall survival.